Abstract | SCOPE: Intestinal mucositis is a common side effect of the chemotherapeutic agent doxorubicin, which is characterized by severe Toll-like receptor (TLR) 2-mediated inflammation. The dietary fiber pectin is shown to prevent this intestinal inflammation through direct inhibition of TLR2 in a microbiota-independent manner. Recent in vitro studies show that inhibition of TLR2 is determined by the number and distribution of methyl- esters of pectins. Therefore, it is hypothesized that the degree of methyl-esterification (DM) and the degree of blockiness (DB) of pectins determine attenuating efficacy on doxorubicin-induced intestinal mucositis. METHODS AND RESULTS: Four structurally different pectins that differed in DM and DB are tested on inhibitory effects on murine TLR2 in vitro, and on doxorubicin-induced intestinal mucositis in mice. These data demonstrate that low DM pectins or intermediate DM pectins with high DB have the strongest inhibitory impact on murine TLR2-1 and the strongest attenuating effect on TLR2-induced apoptosis and peritonitis. Intermediate DM pectin with a low DB is, however, also effective in preventing the induction of doxorubicin-induced intestinal damage. CONCLUSION: These pectin structures with stronger TLR2-inhibiting properties may prevent the development of doxorubicin-induced intestinal damage in patients undergoing chemotherapeutic treatment with doxorubicin.
|
Authors | Martin Beukema, Éva Jermendi, Taco Koster, Kohji Kitaguchi, Bart J de Haan, Marco Alexander van den Berg, Marijke M Faas, Henk A Schols, Paul de Vos |
Journal | Molecular nutrition & food research
(Mol Nutr Food Res)
Vol. 65
Issue 18
Pg. e2100222
(09 2021)
ISSN: 1613-4133 [Electronic] Germany |
PMID | 34268870
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH GmbH. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Antibiotics, Antineoplastic
- Tlr2 protein, mouse
- Toll-Like Receptor 2
- Doxorubicin
- Pectins
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, chemistry, pharmacology)
- Antibiotics, Antineoplastic
(adverse effects)
- Apoptosis
(drug effects)
- Cell Line
- Dose-Response Relationship, Drug
- Doxorubicin
(adverse effects)
- Esterification
- Female
- Intestinal Diseases
(chemically induced, drug therapy, pathology)
- Intestinal Mucosa
(drug effects)
- Intestine, Small
(drug effects, pathology)
- Mice, Inbred C57BL
- Mucositis
(chemically induced, drug therapy, pathology)
- Pectins
(administration & dosage, chemistry, pharmacology)
- Peritonitis
(chemically induced, drug therapy, pathology)
- Structure-Activity Relationship
- Toll-Like Receptor 2
(antagonists & inhibitors, metabolism)
- Mice
|